Opinion - (2025) Volume 15, Issue 4
Received: 02-Jul-2025, Manuscript No. jbpbt-25-178513;
Editor assigned: 04-Jul-2025, Pre QC No. P-178513;
Reviewed: 18-Jul-2025, QC No. Q-178513;
Revised: 23-Jul-2025, Manuscript No. R-178513;
Published:
30-Jul-2025
, DOI: 10.37421/2155-9821.2025.15.689
Citation: Sørensen, Lina K.. ”Techno-Economic Bioprocessing: Efficiency, Costs, and Sustainability.” J Bioprocess Biotech 15 (2025): 689.
Copyright: © 2025 Sørensen K. Lina This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,
distribution and reproduction in any medium, provided the original author and source are credited.
The techno-economic feasibility of industrial bioprocesses is a critical area of research, with significant emphasis placed on the interplay between biological efficiency and economic viability. Optimizing process parameters, scaling up production, and effectively managing feedstock costs are paramount for the successful commercialization of these processes. Furthermore, robust downstream processing and waste valorization strategies play a crucial role in enhancing overall profitability and sustainability, representing a key focus in current industrial biotechnology [1].
The transition from petrochemical feedstocks to renewable alternatives presents both significant challenges and numerous opportunities in the economic evaluation of bio-based chemical production. Methodologies for assessing capital expenditure, operational costs, and market competitiveness are detailed, highlighting the need for process intensification and innovation in enzyme and microbial strain development to improve yields and reduce production costs, thereby driving market adoption [2].
Scaling up biopharmaceutical manufacturing processes introduces complex economic implications, where process design, stringent regulatory compliance, and meticulous quality control contribute substantially to the overall cost of goods. Strategies for cost reduction are being explored through improved upstream productivity, efficient purification techniques, and the implementation of continuous manufacturing approaches, all aimed at making advanced therapies more accessible to a wider population [3].
The techno-economic viability of producing biofuels from lignocellulosic biomass is a subject of intense analysis, with feedstock variability, diverse pretreatment technologies, and downstream conversion efficiencies being key considerations. Integrated biorefinery concepts are emphasized as a means to maximize value from biomass and enhance economic competitiveness against fossil fuels, while challenges related to enzyme costs and lignin valorization are critically assessed [4].
Industrial production of lactic acid through fermentation necessitates a thorough techno-economic analysis, evaluating different fermentation strategies such as batch, fed-batch, and continuous processes, and their direct impact on production costs and product purity. The economics of downstream purification steps, including crystallization and filtration, are also crucial for achieving high-purity lactic acid suitable for food and polymer applications [5].
The economic feasibility of producing recombinant proteins in microbial systems involves a detailed examination of cost drivers in fermentation, media optimization, and protein purification. Strain engineering for enhanced protein expression and the development of cost-effective downstream processing methods are vital for achieving desired product quality and yield, ultimately contributing to more affordable biotherapeutics [6].
The utilization of waste streams as feedstocks for bioprocesses offers significant potential for cost savings and environmental benefits through the valorization of industrial and agricultural byproducts. Analysis covers challenges in feedstock characterization, pretreatment, and the economic viability of converting waste into value-added products such as biogas, bioplastics, and specialty chemicals, representing a sustainable approach to resource management [7].
Enzymatic synthesis of fine chemicals presents economic advantages due to biocatalysis's high selectivity and mild reaction conditions. Examination of cost factors associated with enzyme production, immobilization, and reaction engineering, along with process optimization and enzyme recycling, can significantly improve the economic competitiveness of biocatalytic routes compared to traditional chemical synthesis methods [8].
A comprehensive techno-economic framework for the production of succinic acid via microbial fermentation is essential. This involves analyzing the impact of microbial strains, fermentation conditions, and downstream processing techniques on overall production cost. Achieving high yields and titers is critical for making bio-succinic acid competitive with its petrochemical counterpart, with significant market applications in bioplastics and polymers [9].
Techno-economic assessment of microbial polyhydroxyalkanoate (PHA) production for bioplastics involves evaluating various microbial fermentation strategies, feedstock utilization, and downstream extraction and purification methods. Challenges in achieving cost-competitiveness with conventional plastics are discussed, emphasizing the need for improved productivity and economies of scale in bioplastic manufacturing to foster wider market adoption [10].
The techno-economic feasibility of industrial bioprocesses is deeply rooted in the intricate balance between biological efficiency and economic viability. Critical process parameters, the challenges of scaling up production, and astute feedstock cost management are recognized as foundational elements for successful commercialization. Furthermore, the importance of well-designed downstream processing and innovative waste valorization strategies is highlighted for their significant contributions to both profitability and the overall sustainability of bioprocessing endeavors [1].
The economic evaluation of bio-based chemical production is intrinsically linked to the global shift from petrochemical dependence towards renewable feedstocks. This transition necessitates rigorous assessment of capital expenditures, operational expenses, and the competitive landscape of emerging markets. Process intensification and continuous innovation in areas such as enzyme engineering and microbial strain development are vital for enhancing product yields and reducing manufacturing costs, ultimately accelerating the market penetration of bio-based chemicals [2].
Scaling up biopharmaceutical manufacturing processes introduces a complex web of economic considerations, where the design of the production system, adherence to stringent regulatory frameworks, and the implementation of robust quality control measures significantly influence the cost of goods. Strategies aimed at reducing these costs include enhancing upstream productivity, optimizing purification methodologies, and adopting continuous manufacturing paradigms to facilitate the more accessible provision of advanced therapeutic products [3].
The techno-economic viability of converting lignocellulosic biomass into biofuels is critically dependent on managing feedstock variability, selecting appropriate pretreatment technologies, and optimizing downstream conversion efficiencies. The adoption of integrated biorefinery concepts is advocated as a crucial strategy for maximizing the value derived from biomass resources and improving economic competitiveness against conventional fossil fuels, while specific attention is given to the economic challenges posed by enzyme costs and lignin valorization [4].
For the industrial production of lactic acid through fermentation, a detailed techno-economic analysis is indispensable. This analysis must encompass the comparative evaluation of diverse fermentation strategies, including batch, fed-batch, and continuous processes, to understand their respective impacts on production costs and the purity of the final product. The economic aspects of essential downstream purification steps, such as crystallization and filtration, are also thoroughly examined to ensure the production of high-purity lactic acid suitable for demanding applications in the food and polymer industries [5].
In the context of producing recombinant proteins within microbial systems, a comprehensive understanding of the economic drivers is essential. These drivers include costs associated with fermentation processes, media composition optimization, and protein purification. Advancements in strain engineering for superior protein expression and the development of cost-effective downstream processing techniques are paramount for achieving the required product quality and yield, thereby contributing to the affordability of biotherapeutics [6].
The strategic utilization of waste streams as feedstocks in bioprocesses offers substantial economic and environmental advantages through the effective valorization of industrial and agricultural byproducts. The assessment includes the complexities of feedstock characterization, the selection of suitable pretreatment methods, and the overall economic feasibility of transforming waste materials into valuable products such as biogas, bioplastics, and specialty chemicals, underscoring a sustainable approach to resource utilization [7].
The economic evaluation of enzymatic synthesis for fine chemicals highlights the inherent benefits of biocatalysis, particularly its high selectivity and operation under mild reaction conditions. Detailed examination of the cost components, including enzyme production, immobilization strategies, and reaction engineering, coupled with process optimization and effective enzyme recycling, can significantly enhance the economic competitiveness of biocatalytic pathways when compared to traditional chemical synthesis methods [8].
Developing a robust techno-economic framework for the production of succinic acid via microbial fermentation is crucial for its commercial success. This involves a thorough analysis of how different microbial strains, fermentation parameters, and downstream processing techniques influence the total production cost. Achieving high product yields and titers is a key determinant for bio-succinic acid to compete effectively with its petrochemical-derived counterpart, with significant potential applications in the bioplastics and polymer sectors [9].
The techno-economic assessment of microbial polyhydroxyalkanoate (PHA) production for bioplastics requires careful consideration of various fermentation strategies, feedstock choices, and methods for downstream extraction and purification. The primary challenge lies in achieving cost parity with conventional plastics. This necessitates improvements in production efficiency and realizing economies of scale in the manufacturing of bioplastics to facilitate broader market acceptance and adoption [10].
This collection of research explores the techno-economic feasibility of various industrial bioprocesses. Key themes include optimizing biological efficiency and economic viability, managing feedstock costs, and the importance of downstream processing and waste valorization for profitability and sustainability. The transition to renewable feedstocks in bio-based chemical production is analyzed, alongside strategies for cost reduction in biopharmaceutical manufacturing. Biofuel production from lignocellulosic biomass, industrial lactic acid, recombinant protein, and bioplastic production are examined, with a focus on process design, cost drivers, and market competitiveness. The economic benefits of using waste streams as feedstocks and the advantages of enzymatic synthesis are also discussed. Achieving high yields and cost-competitiveness are recurring goals across these diverse bioprocessing applications.
None
None
Journal of Bioprocessing & Biotechniques received 3351 citations as per Google Scholar report
